HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 01-19-2018, 01:06 PM   #1
donocco
Senior Member
 
Join Date: Oct 2013
Posts: 474
Re: Need input, KADCYLA or TAS116?

SCG

I did a bit more research on TAS-116 and didnt come up with much more. I found the Phase one clinical trial you mentioned in your first post. They are going to try TAS-116 for Her2Nue breast cancer and the non small cell lung carcinoma with the T790 mutation which involves the methionine amino acid molecule replacing a normal Threonine amino acid molecule. I have a slight idea what this means but I wont bore you with it as it is not important in your situation. It is Phase one which means the emphasis is on escalating doses vs toxicity not actual clinical results. You have to trust your gut feelings. Im sorry you are being pressured. If your guts tell you somone is trying to sell you a car you have to listen to them. Talk with your oncologist in depth as to what kind of clinical results she is hoping for. She might have some knowledge through the "grapevine" that hasnt been published yet.

Only 21% of the patients in the GIST Phase 2 study of Tas-116 had vision problems anbd they were not severe and were reversed when the drug was stopped. About 80% of the patients had diahrrea but I imagine this is controlleable with Imodium. Also loss of appetite and wgt loss.

You mentioned Herceptin (Trastuzumab) allergy without going into detail. Weve talked about desensitization procedures before and IGG vs IGE antibody response. There is a desensitization procedure for Herceptin where increasing IV doses of the drug are given every 15 minutes starting with 20 micrograms of the drug and ending with 40 milligrams of the drug. Perhaps this may be of use.

The new and improved lapatanib, Neratanib (Nerlynx) has been FDA approved and perhaps this will be of some value. Diarrhea is the most prominent side effect of Nerlynx.

Hope this helps

Paul
donocco is offline   Reply With Quote
Old 01-19-2018, 03:23 PM   #2
Kim in CA
Senior Member
 
Kim in CA's Avatar
 
Join Date: Sep 2001
Location: California's Gold Country
Posts: 404
Re: Need input, KADCYLA or TAS116?

Hi Supportwife,
I've been fortunate in that my treatments have never been suspended due to low platelets. When my platelets got down to around 100, I started to worry as my doctor said they might withhold treatment if I got down to 90. Fortunately that was the lowest they have gotten so far. After that they came back up and have been pretty steady at around 115-120. I did start taking some papaya leaf powder, but really don't know if that is what made the difference.

Kim
__________________
Diag. Feb 1997 4.5cm IDC <10%ER+, PR-. 5 out of 36 nodes +. Mastectomy followed by 3 rounds Adriamycin/Cytoxin.


5/1997 Hi Dose Chemo w/ Stem cell rescue. Spent 4 weeks in isolation ward. Then 6 weeks radiation.

9/2001 widespread mets to liver. 8 mos Taxotere/Herceptin brought me almost to NED. Stop Taxotere & add Femara .

11/2002 liver resection to remove spot that turned out to be necrosis. Officially NED!

7/2003 Tumor markers rising add Xeloda Disastrous reaction, 8 days hospital, but tumor markers came back to normal!

June -Dec 2004 UW Vaccine Trial.

7/2005 MRI single 11mm brain met
8/2005 Gamma Knife.

Brain MRI @3 months NED!

2006-2011 brain/body still NED

8/04/11 Taking Herceptin break, will monitor with tumor markers.

6/20/12 Tumor markers begin to rise. CA15-3 is 31.3 and Her2 Serum is at 17.1 Decide to repeat in one month.

7/23/12 CA15-3 now 49.3
Her2 Serum 26.8

8/6/12 Back on Herceptin
CA15-3 now 76
Her2 Serum now 49

11/7/12 Add weekly Taxotere for 4 cycles

2/2013 Stopped Taxotere added Perjeta. MRI shows approx. 50% reduction liver mets. CA15-3 still elevated @ 55. Will continue on just Herceptin & Perjeta.

November 2014 Continuing on Herceptin, Perjeta, and
Femara indefinitely. Guess I'm NED again, but watching those tumor markers carefully!

Dec. 2015 PET scan reveals mass in perirectal area of abdomen.biopsy confirms. Still Her2+, but no longer ER+. Bye bye Femara

Jan 2016 Begin Kadcyla

March 2016 PET scan shows tumor now barely visible, still NED everywhere else.
2016/2017 continue Kadcyla

November 2017 brain MRI reveals small focus of T2 hyperintensity with possible 4mm enhancing nodule. Short term follow up MRI suggested. Stay tuned...
Kim in CA is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 11:15 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter